MUVON Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

MUVON Therapeutics General Information

Description

Developer of a biotechnology autologous cell therapy platform designed to facilitate the regeneration of skeletal muscle tissue. The company's platform has the ability to offer the treatment of stress urinary incontinence in women and the treatment of diseases related to skeletal muscle damage or degradation, enabling women to have access to the cure for urinary incontinence and live a healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/o ETH Zürich, Weinbergstrasse 35
  • WEH G-Stock
  • 8092 Zurich
  • Switzerland
+41 075
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • C/o ETH Zürich, Weinbergstrasse 35
  • WEH G-Stock
  • 8092 Zurich
  • Switzerland
+41 075

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MUVON Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 04-May-2023 Completed Clinical Trials - Phase 2
6. Accelerator/Incubator 28-Sep-2022 Completed Clinical Trials - Phase 2
5. Early Stage VC (Series A) 31-May-2021 Completed Startup
4. Seed Round Completed Startup
3. Accelerator/Incubator 22-Apr-2021 Completed Startup
2. Accelerator/Incubator 21-Apr-2021 Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view MUVON Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MUVON Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MUVON Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medical Forge Accelerator/Incubator
Swiss-Israel Lean Launchpad Accelerator/Incubator
Horizon Europe Not-For-Profit Venture Capital
Lichtsteiner Foundation Limited Partner Minority
Wyss Zurich Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

MUVON Therapeutics FAQs

  • When was MUVON Therapeutics founded?

    MUVON Therapeutics was founded in 2020.

  • Where is MUVON Therapeutics headquartered?

    MUVON Therapeutics is headquartered in Zurich, Switzerland.

  • What is the size of MUVON Therapeutics?

    MUVON Therapeutics has 20 total employees.

  • What industry is MUVON Therapeutics in?

    MUVON Therapeutics’s primary industry is Drug Discovery.

  • Is MUVON Therapeutics a private or public company?

    MUVON Therapeutics is a Private company.

  • What is MUVON Therapeutics’s current revenue?

    The current revenue for MUVON Therapeutics is .

  • How much funding has MUVON Therapeutics raised over time?

    MUVON Therapeutics has raised $6.45M.

  • Who are MUVON Therapeutics’s investors?

    Medical Forge, Swiss-Israel Lean Launchpad, Horizon Europe, Lichtsteiner Foundation, and Wyss Zurich are 5 of 7 investors who have invested in MUVON Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process